Bath & Body Works, Inc. (BBWI) To Go Ex-Dividend on February 21st

Bath & Body Works, Inc. (NYSE:BBWI) declared a quarterly dividend on Friday, February 7th,RTT News reports. Stockholders of record on Friday, February 21st will be given a dividend of 0.20 per share on Friday, March 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date of this dividend is Friday, February 21st.

Bath & Body Works has increased its dividend payment by an average of 21.1% annually over the last three years. Bath & Body Works has a dividend payout ratio of 20.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Bath & Body Works to earn $3.65 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 21.9%.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $39.89 on Wednesday. The company has a market cap of $8.64 billion, a price-to-earnings ratio of 9.73, a PEG ratio of 0.88 and a beta of 1.83. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The firm has a 50 day moving average price of $37.60 and a 200 day moving average price of $33.72.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. During the same period last year, the company posted $0.48 EPS. The business’s quarterly revenue was up 3.1% on a year-over-year basis. Sell-side analysts predict that Bath & Body Works will post 3.26 EPS for the current year.

Analyst Upgrades and Downgrades

BBWI has been the subject of a number of research reports. Telsey Advisory Group reiterated an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a report on Monday, November 25th. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Argus reiterated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. upgraded Bath & Body Works from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $41.00 to $47.00 in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $43.56.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.